Cardlytics insider plans sale of 6,676 shares
Cardlytics, Inc. (CDLX) is the issuer for a planned sale of common stock under Rule 144 by Amit Gupta.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Cardlytics, Inc. (CDLX) is the issuer for a planned sale of common stock under Rule 144 by Amit Gupta. The notice covers up to 6,676 shares of common stock held at Fidelity Brokerage Services LLC, with a Rule 144 calculation reference price of $26,908.29 and an expiration date of August 18, 2026.
The shares to be sold arise from restricted stock vesting on August 14, 2026, characterized as a compensation-related transaction by the issuer. The filer notes that the sale includes an amount necessary to cover a tax obligation from the settlement of a vested equity award distribution.
The filing also lists sales of Cardlytics common stock by Amit Gupta during the prior three months: 6,498 shares on July 2, 2026 for $28,560.72, 9,640 shares on July 6, 2026 for $42,361.14, and 6,785 shares on August 17, 2026 for $26,908.63.
Key Figures
Key Terms
Rule 144 regulatory
Restricted Stock Vesting financial
vested equity award distribution financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the Form 144 filing mean for Cardlytics, Inc. (CDLX)?
Why does the Form 144 mention taxes for the Amit Gupta CDLX sale?
What is the role of Fidelity Brokerage Services LLC in this Cardlytics (CDLX) Form 144?
AI-generated analysis. How Rhea-AI works. Not financial advice.